NasdaqCM - Delayed Quote USD

Kiora Pharmaceuticals, Inc. (KPRX)

3.2500
-0.0200
(-0.61%)
At close: May 9 at 4:00:00 PM EDT
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
36,484.4840
13,711.8700
18,678.2590
20,130.3080
Total Liabilities Net Minority Interest
10,724.7080
7,602.2160
7,270.6590
5,551.2600
Total Equity Gross Minority Interest
25,759.7760
6,109.6540
11,407.6000
14,579.0480
Total Capitalization
25,759.7760
6,109.6540
11,407.6000
14,579.0480
Preferred Stock Equity
0.0040
0.0040
--
--
Common Stock Equity
25,759.7720
6,109.6500
11,407.6000
14,579.0480
Capital Lease Obligations
57.1700
106.8910
105.7820
209.4120
Net Tangible Assets
19,072.6760
-2,704.1960
664.4360
3,810.8840
Working Capital
23,697.2990
3,104.0360
4,408.3030
7,381.1620
Invested Capital
25,759.7720
6,109.6500
11,407.6000
14,579.0480
Tangible Book Value
19,072.6720
-2,704.2000
664.4360
3,810.8840
Total Debt
57.1700
106.8910
105.7820
209.4120
Share Issued
3,000.7880
856.1820
199.6070
35.1770
Ordinary Shares Number
3,000.7880
856.1820
199.6070
35.1770
12/31/2021 - 2/13/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers